期刊文献+

蛋白激酶CK2在肿瘤生物学中的作用 被引量:3

Protein Kinase Ⅱ in Cancer Biology
在线阅读 下载PDF
导出
摘要 蛋白激酶CK2是一种在真核细胞中普遍存在的高度保守信使非依赖性丝/苏氨酸蛋白激酶,功能多样,对细胞生长、增殖、凋亡及生物节律等均具有很重要的调控作用。其表达失衡与肿瘤的发生发展关系密切。近年来,CK2的研究取得一些重要的进展,鉴于与肿瘤的发生发展的密切联系,有关蛋白激酶CK2的研究越来越受到人们的关注,尤其是其在肿瘤及其他相关疾病的发生发展中所起的作用以及在肿瘤治疗中的应用。 Protein kinase CK2 is a highly conserved protein serine/threonine kinase that is ubiquitously distributed in eukaryotes,where it functions in a variety of cellular processes, including cell cycle progres- sion, apoptosis, transcription, and viral infection, as well as in tumorigenesis and metastasis. In recent years, many studies suggest that CK2 prevent cells from apoptosis through the regulation of tumor suppressor and oncogene activity. Consequently, CK2 are being considered as a potential therapeutic target of cancer now, and strategies to inhibit CK2 have been ongoing in pre-clinical trials.
作者 魏小华 梁杰
出处 《医学综述》 2011年第1期75-77,共3页 Medical Recapitulate
关键词 蛋白激酶CK2 肿瘤 细胞凋亡 磷酸化 Protein kinase CK2 Tumor Apoptosis Phosphorylation
  • 相关文献

参考文献26

  • 1Pallares J,Llobet D,Santacana M,et al. CK2β is expressed in endometrial carcinoma and has a role in apoptosis resistance and cell proliferation [ J ]. Am J Pathol,2009,174 ( 1 ) :287-296.
  • 2Singh NN, Ramji DP. Protein Kinase CK2, an important regulator of the inflammatory response [ J ]. J Mol Med, 2008,86 ( 8 ) : 887-897.
  • 3Kim JS,Eom JI,Cheong JW,et al. Protein kinase CK2 alpha as an unfavorable prognostic marker and novel therapeutic target in acute myeloid leukemia[ J ]. Clin Cancer Res ,2007,13 ( 3 ) : 1019-1028.
  • 4Shi X, Potvin B, Huang T,et al. A novel casein kinase 2 alpha-subunit regulates membrane protein traffic in the human hepatoma cell line HuH-7[J]. J Biol Chem,2001,276(3) :2075-2082.
  • 5Ahmed K,Gerber DA,Cochet C. Joining the cell survival squad:an emerging role for protein kinase CK2 [ J ]. Trends Cell Bio,2002, 12(5 ) :226-230.
  • 6Perea SE, Gil J, Reyes O, et al. CIGB-300, a novel proapoptotic peptide that impairs the CK2 phosphorylation and exhibits anticancer properties both in vitro and in vivo [ J ]. Mol Cell Biochem, 2008,3169 (1/2) : 163-167.
  • 7Trembley JH, Wang G, Unger G, et al. Protein kinase CK2 in health and disease: CK2:a key player in cancer biology [ J ]. Cell Mol Life Sci ,2009,66 ( 11/12 ) : 1858-1867.
  • 8Seldin D, Landesman-Bollag E, Farago M, et al. CK2 as a positive regulator of Wnt signaling and tumorigenesis [ J ]. Mol Cell Biochem,2005,274(1/2) :63-67.
  • 9Shin S, Lee Y, Kim W, et al. Caspase-2 primes cancer cells for TRAIL-mediated apoptosis by processing procaspase-8 [ J ]. EMBO J,2005,24(20) :3532-3542.
  • 10Wang G, Ahmad KA, Ahmed K,et al. Role of CK2 in regulation of TRAIL induced apoptosis in prostate cancer cells [ J ]. Cancer Res, 2006,66 ( 4 ) : 2242 -2249.

二级参考文献13

  • 1鄂征.基本培养技术.组织培养和分子生物学技术[M].北京:北京出版社,1995.155-156.
  • 2Scheper RJ, Broxterman HJ, Scheffer GL, et al. Overexpression of a M (r) 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance [J]. Cancer Res, 1993,53(7):1475-1479.
  • 3Hoehhauser D, Harris AL. The role of topoisomerase Ⅱ alpha and beta in drug resistance [J]. Cancer Treat Rev, 1993,19(2):181-194.
  • 4Covelli A. SDZ PSC 833:a novel modulator of MDR [J].Tumori, 1997,83 ( 5 Suppl ) :$21-24.
  • 5Naito M, Matsuba Y, Sato S, et al. MS-209,a quinoline-type reversal agent,potentiates antitumor efficacy of docetaxel in multidrug-resistant solid tumor xenograft models [J]. Clin Cancer Res, 2002,8(2):582-588.
  • 6Rowinsky EK, Smith L, Wang YM, et al. Phase Ⅰ and pharmacokinetic study of paclitaxel in combination with biricodar,a novel agent that reverses multidrug resistance conferred by overexpression of both MDR1 and MRP [J]. J Clin Oncol, 1998,16(9):2964-2976.
  • 7Starling J J, Shepard RL, Cao J, et al. Pharmacological characterization of LY335979: a potent cyclopropyldibenzo-suberane modulator of P-glycoprotein [J]. Adv Enzyme Regul, 1997,37:335-347.
  • 8Bezombes C, Maestre N, Laurent G, et al. Restoration of TNF-induced ceramide generation and apoptosis in resistant human leukemia KGla cells by the P-glycoprotein blocker PSC833[J]. FASEB J, 1998,12:101-109.
  • 9Johnstone RW, Cretney E, Smyth MJ. P-glycoprotein protects leukemia cells against caspase-dependent,but not caspase-independent,cell death [J]. Blood, 1999,93(3):1075-1085.
  • 10Fu LW, Zhang YM, Liang Y J, et al. The multidrug resistance of tumour cells was reversed by tetrandrine in vitro and in xenografts derived from human breast adenocarcinoma MCF-7/ADR cells [J]. Eur J Cancer, 2002,38(3):418-426.

共引文献4

同被引文献27

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部